US 11191780
Extracellular matrix compositions for the treatment of cancer or immunological diseases
granted A61KA61K35/12A61K35/33
Quick answer
US patent 11191780 (Extracellular matrix compositions for the treatment of cancer or immunological diseases) held by Adaptive Biologix, Inc. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Adaptive Biologix, Inc.
- Grant date
- Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K35/12, A61K35/33, A61K38/014, A61K45/06